Aspergillus spp. antifungal susceptibility to triazoles and Amphotericin B

被引：0
|
作者：
Iatta, R. [1 ]
Puttilli, M. R. [1 ]
Immediato, D. [1 ]
Fracchia, L. [2 ]
Otranto, D. [1 ]
Cafarchia, C. [1 ]
机构：
[1] Univ Bari, Bari, Italy
[2] Univ Piemonte Orientale, Novara, Italy
来源：
MYCOSES | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P023
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [21] In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp.
    Oakley, KL
    Moore, CB
    Denning, DW
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2726 - 2730
  • [22] Antifungal Therapies for Aspergillus spp.: Present and Future
    Eschenauer, Gregory A.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (01) : 61 - 68
  • [23] Molecular characterization and antifungal susceptibility of Aspergillus spp. in chronic pulmonary aspergillosis during sarcoidosis
    Brun, S.
    Allalou, H.
    Uzunhan, Y.
    Melloul, E.
    Dannaoui, E.
    Izri, A.
    MYCOSES, 2017, 60 : 68 - 69
  • [24] Determination of antifungal susceptibility of Aspergillus spp. responsible for otomycosis by E-test method
    Aktas, E.
    Yigit, N.
    JOURNAL DE MYCOLOGIE MEDICALE, 2009, 19 (02): : 122 - 125
  • [25] Molecular Characterization and Antifungal Susceptibility of Aspergillus spp. among Patients with Underlying Lung Diseases
    Moglad, Ehssan
    Saeed, Samar
    Saeed, Humodi
    Ahmed, Hind
    Salih, Kwathar
    Altayb, Hisham
    Elhag, Wafa
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (10)
  • [26] Evaluation of different in vitro procedures for testing amphotericin B and itraconazole susceptibility of Aspergillus fumigatus -: Antifungal susceptibility testing of Aspergillus fumigatus
    Tortorano, AM
    Dannaoui, E
    Cogliati, M
    Piens, MA
    Rigoni, AL
    Grillot, R
    Viviani, MA
    JOURNAL DE MYCOLOGIE MEDICALE, 2000, 10 (03): : 123 - 127
  • [27] Distribution and susceptibility to amphotericin B and fluconazole of Candida spp. isolated from Taiwan
    Yang, YL
    Ho, YA
    Cheng, HH
    Lo, HJ
    EPIDEMIOLOGY AND INFECTION, 2005, 133 (02): : 325 - 330
  • [28] Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates
    Claudino, A. L. R.
    Peixoto, R. F., Jr.
    Melhem, M. S. C.
    Szeszs, M. W.
    Lyon, J. P.
    Chavasco, J. K.
    Franco, M. C.
    PHARMAZIE, 2008, 63 (04): : 286 - 289
  • [29] Susceptibility to amphotericin B of Candida spp. strains isolated in Ceara, Northeastern Brazil
    da Silva, Cecilia Rocha
    Ferreira Magalhaes, Hemerson Iury
    de Moraes, Manoel Odorico
    Nobre Junior, Helio Vitoriano
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2013, 46 (02) : 244 - 245
  • [30] In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis, RE
    Wiederhold, NP
    Klepser, ME
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 945 - 951
12345